Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
AUTOR(ES)
Ter Chao, Chia
FONTE
Clinics
DATA DE PUBLICAÇÃO
2011
RESUMO
Documentos Relacionados
- Glucosamine: A potential disease-modifying agent in osteoarthritis?
- Evidence for early disease-modifying drugs in rheumatoid arthritis
- Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease
- ACE inhibitors for heart failure: a question of dose
- Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes